NasdaqCM:CPRXBiotechs
Is Catalyst Pharmaceuticals (CPRX) Offering Value After Strong Multi‑Year Share Price Gains
If you are wondering whether Catalyst Pharmaceuticals' current share price still offers value, you are not alone. The stock has attracted attention from investors trying to work out if it is priced fairly.
The share price closed at US$23.23 recently, with returns of a 4.2% decline over 7 days, a 2.9% decline over 30 days, a 0.3% gain year to date, 10.5% over 1 year, 45.9% over 3 years and a very large gain over 5 years.
Recent coverage has focused on the company as part of wider discussions...